OpenVSafe by OpenVAERS
Search V-safe

Y2L-85054-79851

3 vaccinations 16 coded responses 28 check-ins 16 free-text entries 5 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
971 / OR
Registered
2021-11-11
Relationship
Child or adolescent in my care
Guardian
9PB-96345-07428
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-11
    Registered in v-safe
  2. 2021-11-11
    Dose 1 — Pfizer-BioNTech
  3. 2021-11-11
    Health check-in — day 0, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2021-11-12
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Fair · Fever · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-11-13
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-11-14
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Brain fog — Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Severe Mental fog
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-11-15
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Brain fog, Memory impairment — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Mental fogginess and difficulty remembering/following directions
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-11-18
    Survey response — day 7, dose 1, dependent
    MedDRA: Abnormal behaviour, Cognitive disorder — Feeling: Good · Site: Redness, Itching · Fever · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Behavioral and cognitive shifts
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-11-25
    Survey response — day 14, dose 1, dependent
    MedDRA: Disturbance in attention, Restlessness — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Difficulty focusing and sitting still
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-03
    Survey response — day 21, dose 1, dependent
    MedDRA: Behaviour disorder, Office visit, Pruritus — Feeling: Good · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Behavioral challenges, itchiness · Healthcare visit (other): PCP visit
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-12-03
    Report sent to call center — day 21, dose 1, dependent
    Be unable to do their normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-12-04
    Dose 2 — Pfizer-BioNTech
  13. 2021-12-08
  14. 2021-12-09
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Abnormal behaviour — Feeling: Good · Site: Pain, Itching · Headache, Nausea
    Free text: Some behavior struggles
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-12-10
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Decreased appetite — Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Loss of appetite
    MedDRA releases: 2024-11 · check-in free text available
  16. 2021-12-11
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-12-18
    Survey response — day 14, dose 2, dependent
    MedDRA: Brain fog, Unevaluable event — Feeling: Fair · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Impulse control, mental fog
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-12-18
    Report sent to call center — day 14, dose 2, dependent
    Be unable to do their normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  19. 2021-12-22
    Call successful
    Participant prefers to complete VAERS report online
  20. 2021-12-25
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  21. 2022-01-01
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  22. 2022-01-08
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  23. 2022-01-15
    Health check-in — day 42, dose 2, dependent
    Feeling: Fair
    Adult check-in
  24. 2022-03-05
    Survey response — 3 months, dose 2, dependent
    MedDRA: Cognitive disorder — Feeling: Fair · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Negative cognitive impacts
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-03-05
    Report sent to call center — 3 months, dose 2, dependent
    Be unable to do their normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  26. 2022-03-09
  27. 2022-06-02
    Dose 3 — Pfizer-BioNTech
  28. 2022-06-05
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Behaviour disorder, Brain fog — Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Mental fog, behavioral challenges
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-06-06
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Behaviour disorder, Brain fog — Feeling: Good · Site: Redness, Itching · Fatigue or tiredness
    Free text: Behavioral challenges, mental fog
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-06-07
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Behaviour disorder, Brain fog — Feeling: Fair · Site: Redness · Fatigue or tiredness
    Free text: Mental fog and behavioral challenges
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-06-08
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Brain fog — Feeling: Good · Fatigue or tiredness
    Free text: Mental fog
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-06-09
    Survey response — day 7, dose 3, dependent
    MedDRA: Behaviour disorder, Brain fog — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Mental fog, behavioral challenges
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-06-18
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  34. 2022-06-23
    Survey response — day 21, dose 3, dependent
    MedDRA: Behaviour disorder, Brain fog, Emotional disorder, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Mental fog, behavioral challenges, emotion regulation degradation · Healthcare visit (other): In person mental health services
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-06-23
    Report sent to call center — day 21, dose 3, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  36. 2022-06-24
  37. 2022-06-30
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  38. 2022-07-07
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  39. 2022-07-19
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  40. 2022-09-04
    Survey response — 3 months, dose 3, dependent
    MedDRA: Abdominal discomfort, Headache, Migraine, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Frequent headaches/migraines with stomach upset · Healthcare visit (other): Primary care provider
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-09-04
    Report sent to call center — 3 months, dose 3, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  42. 2022-09-06
  43. 2022-09-06
  44. 2022-09-06

Vaccinations

DoseDateManufacturerCo-administered
12021-11-11Pfizer-BioNTech No
22021-12-04Pfizer-BioNTech No
32022-06-02Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-12-03 Unsuccessful
2021-12-18 Successful
2021-12-22
Participant prefers to complete VAERS report online
2022-03-05 Unsuccessful
2022-06-23 Unsuccessful
2022-09-04 Unsuccessful

Free text

Release 10 — days 1–6 daily, dose 1, dependent

2021-11-14

Systemic reaction (other): Severe Mental fog

2021-11-15

Systemic reaction (other): Mental fogginess and difficulty remembering/following directions

Release 10 — day 7, dose 1, dependent

2021-11-18

Systemic reaction (other): Behavioral and cognitive shifts

Release 10 — day 14, dose 1, dependent

2021-11-25

Symptoms: Difficulty focusing and sitting still

Release 10 — day 21, dose 1, dependent

2021-12-03

Symptoms: Behavioral challenges, itchiness
Healthcare visit (other): PCP visit

Release 10 — days 1–6 daily, dose 2, dependent

2021-12-09

Systemic reaction (other): Some behavior struggles

2021-12-10

Systemic reaction (other): Loss of appetite

Release 10 — day 14, dose 2, dependent

2021-12-18

Symptoms: Impulse control, mental fog

Release 11 — 3 months, dose 2, dependent

2022-03-05

Symptoms: Negative cognitive impacts

Release 11 — days 1–6 daily, dose 3, dependent

2022-06-05

Systemic reaction (other): Mental fog, behavioral challenges

2022-06-06

Systemic reaction (other): Behavioral challenges, mental fog

2022-06-07

Systemic reaction (other): Mental fog and behavioral challenges

2022-06-08

Systemic reaction (other): Mental fog

Release 12 — day 7, dose 3, dependent

2022-06-09

Systemic reaction (other): Mental fog, behavioral challenges

Release 12 — day 21, dose 3, dependent

2022-06-23

Symptoms: Mental fog, behavioral challenges, emotion regulation degradation
Healthcare visit (other): In person mental health services

Release 12 — 3 months, dose 3, dependent

2022-09-04

Symptoms: Frequent headaches/migraines with stomach upset
Healthcare visit (other): Primary care provider

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAbdominal discomfort · · ✓
SDBehaviour disorder · · ✓
SDBrain fog · · ✓
SDCognitive disorder · · ✓
SDDisturbance in attention · · ✓
SDEmotional disorder · · ✓
SDHeadache · · ✓
SDMigraine · · ✓
SDPruritus · · ✓
SDRestlessness · · ✓
SDUnevaluable event · · ✓
SROAbnormal behaviour · · ✓
SROBehaviour disorder · · ✓
SROBrain fog · · ✓
SROCognitive disorder · · ✓
SRODecreased appetite · · ✓
SROMemory impairment · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release